Overview
Touchlight is a UK-based CDMO specializing in cell-free enzymatic DNA production using proprietary dbDNA™ technology, offering scalable, high-purity alternatives to plasmid DNA for genetic medicines. They support mRNA, viral and non-viral gene therapies, vaccines, and gene editing from preclinical to GMP stages. Their platform enables rapid manufacturing of grams of DNA with benchtop equipment, addressing limitations of traditional methods.
Frequently asked questions
- What DNA products does Touchlight offer?
- Touchlight manufactures dbDNA™, mbDNA™, and z-dbDNA™—minimal, linear or circular, covalently closed, antibiotic-free DNA constructs produced enzymatically for advanced therapies including AAV production, mRNA, and gene editing.
- What are Touchlight's manufacturing capabilities and scales?
- They provide rapid, scalable DNA production from research use only (RUO) to GMP, with capacity up to 8kg plasmid-equivalent DNA, using disposable benchtop equipment for grams-scale output.
- Does Touchlight support GMP production and regulatory needs?
- Yes, Touchlight offers GMP-certified synthetic DNA as the first globally, supporting clients from preclinical development through clinical supply, licensing, and tech transfer for in-house use.